Aldeyra Therapeutics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001341235-26-000006
- Form type
- 10-Q
- CIK
- 0001341235
- Primary document
- https://www.sec.gov/Archives/edgar/data/1341235/000134123526000006/aldx-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aldeyra Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-3.5M | - | - |
| Net Income | $-3.5M | - | - |
| Eps Basic | -0.06 | - | - |
| Eps Diluted | -0.06 | - | - |
| Total Assets | $66.5M | - | - |
| Total Liabilities | $24.3M | - | - |
| Shareholders Equity | $42.2M | - | - |
| Operating Cash Flow | $-5.1M | - | - |